TABLE 1

Medications for the treatment of acute anxiety in hospitalized patients with COVID-19 infection

MedicationDoseRouteCaution
Alprazolam0.125–0.25 mg,3 times dailyBy mouthRespiratory depression
Lorazepam0.5–1 mg, 3 times dailyBy mouth, intramuscular, intravenousaRespiratory depression
Gabapentin100–300 mg, 3 times dailyBy mouthRenal clearance
Hydroxyzine25–50 mg, 3 times dailyBy mouthQTc monitoring
Olanzapine2.5–5 mg, 3 times dailyBy mouthQTc monitoring
Quetiapine25–50 mg, 3 times dailyBy mouthQTc monitoring
Haloperidol0.5–1 mg, 3 times dailyBy mouth, intramuscular, intravenousaQTc monitoring

  • ↵a For intravenous dosing, use half of the oral dose.